A041501: Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Oct 19, 2026 - P3 | N=303 | Recruiting | Sponsor: Alliance for Clinical Trials in Oncology | Trial completion date: Aug 2027 ➔ Apr 2028 | Trial primary completion date: Mar 2027 ➔ Nov 2027
Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD22
|